18127-43-0 Usage
Uses
Used in Pharmaceutical Industry:
4-Pyrimidinecarboxylic acid, 2,6-dichloro-, ethyl ester is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 4-Pyrimidinecarboxylic acid, 2,6-dichloro-, ethyl ester is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its properties contribute to the creation of effective compounds for agricultural use.
Used in Chemical Research:
4-Pyrimidinecarboxylic acid, 2,6-dichloro-, ethyl ester is utilized in chemical research as a reagent for the synthesis of various organic compounds. Its versatility in reactions makes it a valuable tool for exploring new chemical pathways and developing novel compounds.
Safety Considerations:
It is important to handle 4-Pyrimidinecarboxylic acid, 2,6-dichloro-, ethyl ester with caution and follow proper safety protocols due to its potential health and environmental hazards. Proper handling, storage, and disposal measures should be implemented to minimize risks associated with 4-Pyrimidinecarboxylic acid, 2,6-dichloro-, ethyl ester.
Check Digit Verification of cas no
The CAS Registry Mumber 18127-43-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,1,2 and 7 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 18127-43:
(7*1)+(6*8)+(5*1)+(4*2)+(3*7)+(2*4)+(1*3)=100
100 % 10 = 0
So 18127-43-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H6Cl2N2O2/c1-2-13-6(12)4-3-5(8)11-7(9)10-4/h3H,2H2,1H3
18127-43-0Relevant articles and documents
RAS INHIBITORS AND METHODS OF USING THE SAME
-
Paragraph 000150, (2021/08/06)
Provided herein are compounds identified as inhibitors of KRAS protein activity that can be used to treat various diseases and disorders, such as cancer.
3-METHYL-2- ( (2S) -2- (4- (3-METHYL-L, 2, 4-0XADIAZ0L-5-YL) PHENYL) MORPHOLINO) -6- (PYRIMIDIN-4-YL) PYRIMIDIN-4 (3H) -ONE AS TAU PROTEIN KINASE INHIBITOR
-
Page/Page column 10; 12, (2009/04/25)
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g.
6-PYRIMIDINYL-PYRIMID-2-ONE DERIVATIVE
-
Page/Page column 10; 12, (2009/04/25)
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g.
INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
-
Page/Page column 91, (2008/06/13)
The present invention relates to a production method of an optically active morpholine compound represented by the formula 10, which includes the following steps: wherein each symbol is as defined in the specification. The present invention also relates t
